Zhitong Finance App News, Livzon Pharmaceuticals (01513.HK) issued an announcement. Lifou Pharmaceutical Group Co., Ltd. (hereinafter referred to as the “Company”) held the 19th meeting of the company's 11th board of directors and the 10th meeting of the 11th board of supervisors on September 27, 2024 to review and pass the “Proposal on Closing Capital Raising Investment Projects and Permanently Supplementing Liquidity by Raising Savings”, agreeing that the company will raise capital for investment projects (including “Advanced Development and Industrialization Upgrading Project of the Apra Series of Innovative Products”, “Lizhu Group Beijiang Pharmaceutical Co., Ltd.” The “Relocation and Expansion Project (Phase I)”, the “Lizhu Group Limin Pharmaceutical Factory Bagged Infusion Workshop Technical Improvement Project”, “Long-term Microsphere Technology R&D Platform Construction Project” and “Supplemental Liquidity and Bank Loan Repayment”) were settled, and the balance raised capital of 157 million yuan (including interest income) was permanently replenished with working capital (the actual amount is based on the bank account balance on the day the funds are transferred out). After the savings raised funds are transferred out, the special fund-raising account set up at the bank will no longer be used, and the company will complete the account sale procedure as soon as possible.

Zhitong Finance App News, Livzon Pharmaceuticals (01513.HK) issued an announcement. Lifou Pharmaceutical Group Co., Ltd. (hereinafter referred to as the “Company”) held the 19th meeting of the company's 11th board of directors and the 10th meeting of the 11th board of supervisors on September 27, 2024 to review and pass the “Proposal on Closing Capital Raising Investment Projects and Permanently Supplementing Liquidity by Raising Savings”, agreeing that the company will raise capital for investment projects (including “Advanced Development and Industrialization Upgrading Project of the Apra Series of Innovative Products”, “Lizhu Group Beijiang Pharmaceutical Co., Ltd.” The “Relocation and Expansion Project (Phase I)”, the “Lizhu Group Limin Pharmaceutical Factory Bagged Infusion Workshop Technical Improvement Project”, the “Long-Term Microsphere Technology R&D Platform Construction Project” and “Supplemental Liquidity and Bank Loan Repayment”) were settled, and the balance raised capital of 157 million yuan (including interest income) was permanently replenished with working capital (the actual amount is based on the bank account balance on the day the funds are transferred out). After the savings raised funds are transferred out, the special fund-raising account set up at the bank will no longer be used, and the company will complete the account sale procedure as soon as possible.